KDOQITM News
- New Leadership for National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative
- Diabetes and Kidney Failure: A New Tool to Break the Cycle
- KDOQI Disclosure and COI Policies
The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI ™)
The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI ™) or KDOQI ™ provides evidence-based clinical practice guidelines for all stages of chronic kidney disease and related complications. KDOQI expands the Dialysis Outcomes Quality Initiative or DOQI, a project begun by the National Kidney Foundation in 1997 and recognized throughout the world for improving the care of dialysis patients. There are 12 current sets of KDOQI guidelines.
- Diabetes and Chronic Kidney Disease
- Anemia in Chronic Kidney Disease
- Hemodialysis Adequacy
- Peritoneal Dialysis
- Vascular Access
- Anemia Management
- Nutrition
- Chronic Kidney Disease: Evaluation, Classification, and Stratification
- Dyslipidemia
- Bone Metabolism and Disease in Chronic Kidney Disease
- Bone Metabolism and Disease in Chronic Kidney Disease in Children
- Hypertension and Antihypertensive Agents in Chronic Kidney Disease
- Cardiovascular Disease in Dialysis Patients
More information about the Clinical Practice Guidelines
The Guidelines have been widely adopted in the United States and abroad and have been a stimulus for several national renal organizations to develop their own Guidelines. They have been translated into at least a dozen languages, have been the focus of numerous quality improvement activities, and have served as the basis for clinical performance measures developed by Center for Medicare and Medicaid Services and other organizations.
KDOQITM is a trademark of the National Kidney Foundation, Inc.
